Literature DB >> 2173691

Prostanoid-induced blood-aqueous barrier breakdown in rabbits involves the EP2 receptor subtype.

C E Protzman1, D F Woodward.   

Abstract

Previous studies on prostanoid-induced blood-aqueous barrier disruption have been predominantly restricted to studies on natural prostanoids and the highly selective DP-receptor agonist BW245C, which was inactive. The pharmacology of prostanoid-induced blood-aqueous barrier breakdown in rabbits has been extended in these studies by determining the activity of additional prostanoid receptor agonists which are relatively selective according to the current classification for prostanoid receptors. Prostanoid effects were evaluated by measuring plasma albumin leakage into the aqueous humor as an indicator of blood-aqueous barrier breakdown. EP1 and EP3 receptor subtype agonists were ineffective in altering the blood-aqueous barrier, but the relatively selective EP2 agonist 11-deoxy prostaglandin E1 had a dose-dependent disruptive effect on the blood-aqueous barrier. In contrast, FP, IP and TP receptor agonists were ineffective in disrupting the blood-aqueous barrier. Taken together, these data imply that the EP2 receptor subtype, as a singular entity, may account for the rapid disruption of the rabbit blood-aqueous barrier that typically occurs in response to prostanoids.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173691

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  The EP2 receptor is the predominant prostanoid receptor in the human ciliary muscle.

Authors:  T Matsuo; M S Cynader
Journal:  Br J Ophthalmol       Date:  1993-02       Impact factor: 4.638

Review 2.  Prostaglandin analogues in the treatment of glaucoma.

Authors:  C Lindén; A Alm
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

3.  Nifedipine enhances the relaxant effects of cyclo-oxygenase inhibitors on the bovine ciliary muscle.

Authors:  Mustafa Toker; Ihsan Bagcivan; Aysen Topalkara; Baris Karadas; Nedim Durmus; Ahmet Parlak; Tijen Kaya
Journal:  J Ocul Pharmacol Ther       Date:  2008-12       Impact factor: 2.671

4.  Effects of latanoprost and dipivefrin, alone or combined, on intraocular pressure and on blood-aqueous barrier permeability.

Authors:  I Widengård; O Mäepea; A Alm
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

5.  Studies on a novel series of acyl ester prodrugs of prostaglandin F2 alpha.

Authors:  A Cheng-Bennett; M F Chan; G Chen; T Gac; M E Garst; C Gluchowski; L J Kaplan; C E Protzman; M B Roof; G Sachs
Journal:  Br J Ophthalmol       Date:  1994-07       Impact factor: 4.638

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.